Sirolimus Is an Acceptable Alternative to Tacrolimus for Graft-versus-Host Disease Prophylaxis after Haploidentical Peripheral Blood Stem Cell Transplantation with Post-Transplantation Cyclophosphamide-Reference-Cited by-同舟云学术

Sirolimus Is an Acceptable Alternative to Tacrolimus for Graft-versus-Host Disease Prophylaxis after Haploidentical Peripheral Blood Stem Cell Transplantation with Post-Transplantation Cyclophosphamide

Published:2024-02 Issue:2 Volume:30 Page:229.e1-229.e11
ISSN:2666-6367
Container-title:Transplantation and Cellular Therapy
language:en
Short-container-title:Transplantation and Cellular Therapy

Author:

Elmariah Hany^ORCID,Otoukesh Salman^ORCID,Kumar Ambuj^ORCID,Ali Haris,Arslan Shukaib,Shouse Geoffrey^ORCID,Pourhassan Hoda,Nishihori Taiga,Faramand Rawan^ORCID,Mishra Asmita,Khimani Farhad,Fernandez Hugo,Lazaryan Aleksandr,Nieder Michael,Perez Lia,Liu Hien,Nakamura Ryotaro,Pidala Joseph,Marcucci Guido,Forman Stephen J.,Anasetti Claudio,Locke Frederick,Bejanyan Nelli^ORCID,Al Malki Monzr M.

Funder

Bristol-Myers Squibb

Publisher

Elsevier BV

Subject

Transplantation,Cell Biology,Hematology,Molecular Medicine,Immunology and Allergy

Reference45 articles.

1. Hematopoietic stem-cell transplantation;Copelan;N Engl J Med,2006

2. HLA match likelihoods for hematopoietic stem-cell grafts in the US Registry;Gragert;N Engl J Med,2014

4. The US National Marrow Donor Program role in unrelated donor hematopoietic cell transplantation;Confer;Bone Marrow Transplant,2008

5. Human umbilical cord blood as a potential source of transplantable hematopoietic stem/progenitor cells;Broxmeyer;Proc Natl Acad Sci U S A,1989

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Incidence, risk factors and therapy response of acute graft-versus-host disease after myeloablative hematopoietic stem cell transplantation with posttransplant cyclophosphamide;Bone Marrow Transplantation;2024-08-24

2. Comparison of Three Graft-versus-Host Disease Prophylaxis Strategies after T Cell-Replete Haploidentical Hematopoietic Transplantation: Tacrolimus versus Calcineurin Inhibitors + Mycophenolate Mofetil versus Sirolimus + Mycophenolate Mofetil;Transplantation and Cellular Therapy;2024-08

3. Lower Weight-Based Mycophenolate Mofetil Dosing is Associated with Superior Outcomes after Haploidentical Hematopoietic Cell Transplant with Post-transplant Cyclophosphamide;Transplantation and Cellular Therapy;2024-08

4. The use of haploidentical stem cell transplant as an alternative donor source in patients with decreased access to matched unrelated donors;Hematology;2024-05-16

5. Post‐transplant‐cyclophosphamide and short‐term Everolimus as graft‐versus‐host‐prophylaxis in patients with relapsed/refractory lymphoma and myeloma—Final results of the phase II OCTET‐EVER trial;European Journal of Haematology;2024-04-14